Kim, U., Lee, C., Jo, J., Lee, H., Choi, Y., Son, J., . . . Kim, T. (2013). A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study. The Korean Academy of Medical Sciences.
Citação norma ChicagoKim, Ung, et al. A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients With Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study. The Korean Academy of Medical Sciences, 2013.
Citação norma MLAKim, Ung, et al. A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients With Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study. The Korean Academy of Medical Sciences, 2013.